These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy. Gakis G; Ngamsri T; Rausch S; Mischinger J; Todenhöfer T; Schwentner C; Schmid MA; Hassan FA; Renninger M; Stenzl A World J Urol; 2015 Oct; 33(10):1429-37. PubMed ID: 25595732 [TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study. Necchi A; Anichini A; Raggi D; Briganti A; Massa S; Lucianò R; Colecchia M; Giannatempo P; Mortarini R; Bianchi M; Farè E; Monopoli F; Colombo R; Gallina A; Salonia A; Messina A; Ali SM; Madison R; Ross JS; Chung JH; Salvioni R; Mariani L; Montorsi F J Clin Oncol; 2018 Dec; 36(34):3353-3360. PubMed ID: 30343614 [TBL] [Abstract][Full Text] [Related]
6. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease? Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347 [TBL] [Abstract][Full Text] [Related]
8. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252 [TBL] [Abstract][Full Text] [Related]
9. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174 [TBL] [Abstract][Full Text] [Related]
10. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection. Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082 [TBL] [Abstract][Full Text] [Related]
11. Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only. Cajipe M; Wang H; Elshabrawy A; Kaushik D; Liss M; Svatek R; Wu S; Chowdhury WH; Ramamurthy C; Mansour AM Urol Oncol; 2020 Apr; 38(4):231-239. PubMed ID: 31956078 [TBL] [Abstract][Full Text] [Related]
12. Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes. Voskuilen CS; Seiler R; Rink M; Poyet C; Noon AP; Roghmann F; Necchi A; Aziz A; Lavollé A; Young MJ; Marks P; Saba K; van Rhijn BWG; Fransen van de Putte EE; Ablat J; Black PC; Sosnowski R; Dobruch J; Kumar P; Jallad S; Catto JWF; Xylinas E; Hendricksen K; Eur Urol Focus; 2020 Nov; 6(6):1226-1232. PubMed ID: 30559065 [TBL] [Abstract][Full Text] [Related]
13. Comparison of pathological staging and grading of urothelial bladder carcinoma in post-transurethral resection and post-radical cystectomy specimens. Poletajew S; Fus Ł; Walędziak M; Pomada P; Ciechańska J; Wasiutyński A; Radziszewski P; Górnicka B Pol J Pathol; 2014 Dec; 65(4):305-12. PubMed ID: 25693085 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer. Sagaster P; Flamm J; Flamm M; Mayer A; Donner G; Oberleitner S; Havelec L; Lepsinger L; Ludwig H Eur J Cancer; 1996 Jul; 32A(8):1320-4. PubMed ID: 8869093 [TBL] [Abstract][Full Text] [Related]
15. Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease. Tollefson MK; Boorjian SA; Farmer SA; Frank I World J Urol; 2012 Dec; 30(6):795-9. PubMed ID: 22447397 [TBL] [Abstract][Full Text] [Related]
16. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder. Abufaraj M; Shariat SF; Foerster B; Pozo C; Moschini M; D'Andrea D; Mathieu R; Susani M; Czech AK; Karakiewicz PI; Seebacher V World J Urol; 2018 Feb; 36(2):231-240. PubMed ID: 29127452 [TBL] [Abstract][Full Text] [Related]
17. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer. Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637 [TBL] [Abstract][Full Text] [Related]
18. Value of repeat radical transurethral resection for selected patients with muscle-invasive bladder cancer. Li Z; Li Y; Lu Q; Chen J ANZ J Surg; 2018 Oct; 88(10):1033-1036. PubMed ID: 29974604 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)]. Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191 [TBL] [Abstract][Full Text] [Related]
20. Role of Maximal Transurethral Resection Preceding Partial Cystectomy for Muscle-Invasive Bladder Cancer. Ham WS; Park JS; Jang WS; Kim J Ann Surg Oncol; 2024 Feb; 31(2):1384-1392. PubMed ID: 37884699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]